Registro:

Referencias:

• Akdemir, K.C., Jain, A.K., Allton, K., Aronow, B., Xu, X., Cooney, A.J., Li, W., Barton, M.C., Genome-wide profiling reveals stimulus-specific functions of p53 during differentiation and DNA damage of human embryonic stem cells (2014) Nucleic Acids Res, 42 (1), pp. 205-223
• Aladjem, M.I., Spike, B.T., Rodewald, L.W., Hope, T.J., Klemm, M., Jaenisch, R., Wahl, G.M., ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage (1998) Curr Biol, 8 (3), pp. 145-155
• Ali, S.H., Decaprio, J.A., Cellular transformation by SV40 large T antigen: Interaction with host proteins (2001) Semin Cancer Biol, 11 (1), pp. 15-23
• Aloni-Grinstein, R., Shetzer, Y., Kaufman, T., Rotter, V., P53: The barrier to cancer stem cell formation (2014) FEBS Lett, 588, pp. 2580-2589
• Asher, G., Tsvetkov, P., Kahana, C., Shaul, Y., A mechanism of ubiquitin-independent protea-somal degradation of the tumor suppressors p53 and p73 (2005) Genes Dev, 19 (3), pp. 316-321
• Bensaad, K., Tsuruta, A., Selak, M.A., Vidal, M.N., Nakano, K., Bartrons, R., Gottlieb, E., Vousden, K.H., TIGAR, a p53-inducible regulator of glycolysis and apoptosis (2006) Cell, 126 (1), pp. 107-120
• Berk, A.J., Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus (2005) Oncogene, 24 (52), pp. 7673-7685
• Bischof, O., Kirsh, O., Pearson, M., Itahana, K., Pelicci, P.G., Dejean, A., Deconstructing PML-induced premature senescence (2002) Embo J, 21 (13), pp. 3358-3369
• Bocchetta, M., Eliasz, S., De Marco, M.A., Rudzinski, J., Zhang, L., Carbone, M., The SV40 large T antigen-p53 complexes bind and activate the insulin-like growth factor-I promoter stimulating cell growth (2008) Cancer Res, 68 (4), pp. 1022-1029
• Boeckler, F.M., Joerger, A.C., Jaggi, G., Rutherford, T.J., Veprintsev, D.B., Fersht, A.R., Targeted rescue of a destabilized mutant of p53 by an in silico screened drug (2008) Proc Natl Acad Sci U S A, 105 (30), pp. 10360-10365
• Bourdon, J.C., Fernandes, K., Murray-Zmijewski, F., Liu, G., Diot, A., Xirodimas, D.P., Saville, M.K., Lane, D.P., P53 isoforms can regulate p53 transcriptional activity (2005) Genes Dev, 19 (18), pp. 2122-2137
• Brosh, R., Rotter, V., When mutants gain new powers: News from the mutant p53 field (2009) Nat Rev Cancer, 9 (10), pp. 701-713
• Budanov, A.V., Karin, M., P53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling (2008) Cell, 134 (3), pp. 451-460
• Budanov, A.V., Sablina, A.A., Feinstein, E., Koonin, E.V., Chumakov, P.M., Regeneration of perox-iredoxins by p53-regulated sestrins, homologs of bacterial AhpD (2004) Science, 304 (5670), pp. 596-600
• Cano, C.E., Gommeaux, J., Pietri, S., Culcasi, M., Garcia, S., Seux, M., Barelier, S., Carrier, A., Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function (2009) Cancer Res, 69 (1), pp. 219-226
• Chene, P., Inhibition of the p53-hdm2 interaction with low molecular weight compounds (2004) Cell Cycle, 3 (4), pp. 460-461
• Comel, A., Sorrentino, G., Capaci, V., Del Sal, G., The cytoplasmic side of p53's oncosuppressive activities (2014) FEBS Lett, 588, pp. 2600-2609
• Crighton, D., Wilkinson, S., O'prey, J., Syed, N., Smith, P., Harrison, P.R., Gasco, M., Ryan, K.M., DRAM, a p53-induced modulator of autophagy, is critical for apoptosis (2006) Cell, 126 (1), pp. 121-134
• Culotta, E., Koshland, D.E., Jr., P53 sweeps through cancer research (1993) Science, 262 (5142), pp. 1958-1961
• Dai, C., Gu, W., P53 post-translational modification: Deregulated in tumorigenesis (2010) Trends Mol Med, 16 (11), pp. 528-536
• De Stanchina, E., Querido, E., Narita, M., Davuluri, R.V., Pandolfi, P.P., Ferbeyre, G., Lowe, S.W., PML is a direct p53 target that modulates p53 effector functions (2004) Mol Cell, 13 (4), pp. 523-535
• Dittmer, D., Pati, S., Zambetti, G., Chu, S., Teresky, A.K., Moore, M., Finlay, C., Levine, A.J., Gain of function mutations in p53 (1993) Nat Genet, 4 (1), pp. 42-46
• Dohner, H., Fischer, K., Bentz, M., Hansen, K., Benner, A., Cabot, G., Diehl, D., Stilgenbauer, S., P53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias (1995) Blood, 85 (6), pp. 1580-1589
• Donehower, L.A., Harvey, M., Slagle, B.L., Mc Arthur, M.J., Montgomery, C.A., Jr., Butel, J.S., Bradley, A., Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours (1992) Nature, 356 (6366), pp. 215-221
• Doyle, J.M., Gao, J., Wang, J., Yang, M., Potts, P.R., MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases (2010) Mol Cell, 39 (6), pp. 963-974
• Drane, P., Bravard, A., Bouvard, V., May, E., Reciprocal down-regulation of p53 and SOD2 gene expression-implication in p53 mediated apoptosis (2001) Oncogene, 20 (4), pp. 430-439
• El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Vogelstein, B., WAF1, a potential mediator of p53 tumor suppression (1993) Cell, 75 (4), pp. 817-825
• Essmann, F., Schulze-Osthoff, K., Translational approaches targeting the p53 pathway for anticancer therapy (2012) Br J Pharmacol, 165 (2), pp. 328-344
• Feng, Z., Zhang, H., Levine, A.J., Jin, S., The coordinate regulation of the p53 and mTOR pathways in cells (2005) Proc Natl Acad Sci U S A, 102 (23), pp. 8204-8209
• Feng, Z., Hu, W., De Stanchina, E., Teresky, A.K., Jin, S., Lowe, S., Levine, A.J., The regulation of AMPK beta1, TSC2, and PTEN expression by p53: Stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways (2007) Cancer Res, 67 (7), pp. 3043-3053
• Freed-Pastor, W.A., Prives, C., Mutant p53: One name, many proteins (2012) Genes Dev, 26 (12), pp. 1268-1286
• Frezza, C., Martins, C.P., From tumor prevention to therapy: Empowering p53 to fight back (2012) Drug Resist Updat, 15 (5-6), pp. 258-267
• Green, D.R., Kroemer, G., Cytoplasmic functions of the tumour suppressor p53 (2009) Nature, 458 (7242), pp. 1127-1130
• Grochola, L.F., Zeron-Medina, J., Meriaux, S., Bond, G.L., Single-nucleotide polymorphisms in the p53 signaling pathway (2010) Cold Spring Harb Perspect Biol 2(5), 2 (5), pp. a001032
• Gu, B., Zhu, W.G., Surf the post-translational modification network of p53 regulation (2012) Int J Biol Sci, 8 (5), pp. 672-684
• Halaby, M.J., Yang, D.Q., P53 translational control: A new facet of p53 regulation and its implication for tumorigenesis and cancer therapeutics (2007) Gene, 395 (1-2), pp. 1-7
• Hamada, M., Fujiwara, T., Hizuta, A., Gochi, A., Naomoto, Y., Takakura, N., Takahashi, K., Orita, K., The p53 gene is a potent determinant of chemosensitivity and radiosensitivity in gastric and colorectal cancers (1996) J Cancer Res Clin Oncol, 122 (6), pp. 360-365
• Han, M.K., Song, E.K., Guo, Y., Ou, X., Mantel, C., Broxmeyer, H.E., SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization (2008) Cell Stem Cell, 2 (3), pp. 241-251
• Hanel, W., Marchenko, N., Xu, S., Yu, S.X., Weng, W., Moll, U., Two hot spot mutant p53 mouse models display differential gain of function in tumorigenesis (2013) Cell Death Differ, 20 (7), pp. 898-909
• Hermeking, H., Eick, D., Mediation of c-Myc-induced apoptosis by p53 (1994) Science, 265 (5181), pp. 2091-2093
• Hoe, K.K., Verma, C.S., Lane, D.P., Drugging the p53 pathway: Understanding the route to clinical efficacy (2014) Nat Rev Drug Discov, 13 (3), pp. 217-236
• Honda, R., Yasuda, H., Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53 (1999) Embo J, 18 (1), pp. 22-27
• Huibregtse, J.M., Scheffner, M., Howley, P.M., Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53 (1993) Mol Cell Biol, 13 (2), pp. 775-784
• Jacks, T., Remington, L., Williams, B.O., Schmitt, E.M., Halachmi, S., Bronson, R.T., Weinberg, R.A., Tumor spectrum analysis in p53-mutant mice (1994) Curr Biol, 4 (1), pp. 1-7
• Kandoth, C., Schultz, N., Cherniack, A.D., Akbani, R., Liu, Y., Shen, H., Robertson, A.G., Levine, D.A., Integrated genomic characterization of endometrial carcinoma (2013) Nature, 497 (7447), pp. 67-73
• Kawauchi, K., Araki, K., Tobiume, K., Tanaka, N., P53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation (2008) Nat Cell Biol, 10 (5), pp. 611-618
• Kenzelmann Broz, D., Attardi, L.D., In vivo analysis of p53 tumor suppressor function using genetically engineered mouse models (2010) Carcinogenesis, 31 (8), pp. 1311-1318
• Kim, S.H., Dass, C.R., P53-targeted cancer pharmacotherapy: Move towards small molecule compounds (2011) J Pharm Pharmacol, 63 (5), pp. 603-610
• Kondoh, H., Lleonart, M.E., Gil, J., Wang, J., Degan, P., Peters, G., Martinez, D., Beach, D., Glycolytic enzymes can modulate cellular life span (2005) Cancer Res, 65 (1), pp. 177-185
• Kruse, J.P., Gu, W., Modes of p53 regulation (2009) Cell, 137 (4), pp. 609-622
• Ladelfa, M.F., Peche, L.Y., Toledo, M.F., Laiseca, J.E., Schneider, C., Monte, M., Tumor-specific MAGE proteins as regulators of p53 function (2011) Cancer Lett, 325 (1), pp. 11-17
• Ladelfa, M.F., Toledo, M.F., Laiseca, J.E., Monte, M., Interaction of p53 with tumor suppressive and oncogenic signaling pathways to control cellular reactive oxygen species production (2012) Antioxid Redox Signal, 15 (6), pp. 1749-1761
• Lane, D.P., Cancer. P53, guardian of the genome (1992) Nature, 358 (6381), pp. 15-16
• Lane, D.P., Crawford, L.V., T antigen is bound to a host protein in SV40-transformed cells (1979) Nature, 278 (5701), pp. 261-263
• Lane, D.P., Cheok, C.F., Lain, S., P53-based cancer therapy (2010) Cold Spring Harb Perspect Biol, 2 (9), pp. a001222
• Lang, G.A., Iwakuma, T., Suh, Y.A., Liu, G., Rao, V.A., Parant, J.M., Valentin-Vega, Y.A., Lozano, G., Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome (2004) Cell, 119 (6), pp. 861-872
• Laronga, C., Yang, H.Y., Neal, C., Lee, M.H., Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression (2000) J Biol Chem, 275 (30), pp. 23106-23112
• Levine, A.J., P53, the cellular gatekeeper for growth and division (1997) Cell, 88 (3), pp. 323-331
• Lee, S.W., Seong, M.W., Jeon, Y.J., Chung, C.H., Ubiquitin E3 ligases controlling p53 stability (2012) Anim Cells Syst, 16 (3), pp. 173-182
• Li, H., Fan, X., Kovi, R.C., Jo, Y., Moquin, B., Konz, R., Stoicov, C., Houghton, J., Spontaneous expression of embryonic factors and p53 point mutations in aged mesenchymal stem cells: A model of age-related tumorigenesis in mice (2007) Cancer Res, 67 (22), pp. 10889-10898
• Lin, T., Chao, C., Saito, S., Mazur, S.J., Murphy, M.E., Appella, E., Xu, Y., P53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression (2005) Nat Cell Biol, 7 (2), pp. 165-171
• Liu, X., Yue, P., Khuri, F.R., Sun, S.Y., P53 upregulates death receptor 4 expression through an intronic p53 binding site (2004) Cancer Res, 64 (15), pp. 5078-5083
• Llanos, S., Clark, P.A., Rowe, J., Peters, G., Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus (2001) Nat Cell Biol, 3 (5), pp. 445-452
• Lu, W., Pochampally, R., Chen, L., Traidej, M., Wang, Y., Chen, J., Nuclear exclusion of p53 in a subset of tumors requires MDM2 function (2000) Oncogene, 19 (2), pp. 232-240
• Luo, J., Nikolaev, A.Y., Imai, S., Chen, D., Su, F., Shiloh, A., Guarente, L., Gu, W., Negative control of p53 by Sir2alpha promotes cell survival under stress (2001) Cell, 107 (2), pp. 137-148
• Machado-Silva, A., Perrier, S., Bourdon, J.C., P53 family members in cancer diagnosis and treatment (2010) Semin Cancer Biol, 20 (1), pp. 57-62
• Maddocks, O.D., Vousden, K.H., Metabolic regulation by p53 (2011) J Mol Med (Berl), 89 (3), pp. 237-245
• Malkin, D., Li-fraumeni syndrome (2011) Genes Cancer, 2 (4), pp. 475-484
• Marcar, L., Maclaine, N.J., Hupp, T.R., Meek, D.W., Mage-A cancer/testis antigens inhibit p53 function by blocking its interaction with chromatin (2010) Cancer Res, 70 (24), pp. 10362-10370
• Marine, J.C., Jochemsen, A.G., Mdmx as an essential regulator of p53 activity (2005) Biochem Biophys Res Commun, 331 (3), pp. 750-760
• Markey, M.P., Regulation of MDM4 (2008) Front Biosci (Landmark Ed), 16, pp. 1144-1156
• Martins, C.P., Brown-Swigart, L., Evan, G.I., Modeling the therapeutic efficacy of p53 restoration in tumors (2006) Cell, 127 (7), pp. 1323-1334
• Mathupala, S.P., Ko, Y.H., Pedersen, P.L., Hexokinase II: Cancer’s double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria (2006) Oncogene, 25 (34), pp. 4777-4786
• Matoba, S., Kang, J.G., Patino, W.D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P.J., Hwang, P.M., P53 regulates mitochondrial respiration (2006) Science, 312 (5780), pp. 1650-1653
• Meek, D.W., Knippschild, U., Posttranslational modification of MDM2 (2003) Mol Cancer Res, 1 (14), pp. 1017-1026
• Mills, A.A., Zheng, B., Wang, X.J., Vogel, H., Roop, D.R., Bradley, A., P63 is a p53 homologue required for limb and epidermal morphogenesis (1999) Nature, 398 (6729), pp. 708-713
• Miyashita, T., Reed, J.C., Tumor suppressor p53 is a direct transcriptional activator of the human bax gene (1995) Cell, 80 (2), pp. 293-299
• Moll, U.M., Petrenko, O., The MDM2-p53 interaction (2003) Mol Cancer Res, 1 (14), pp. 1001-1008
• Moll, U.M., Riou, G., Levine, A.J., Two distinct mechanisms alter p53 in breast cancer: Mutation and nuclear exclusion (1992) Proc Natl Acad Sci U S A, 89 (15), pp. 7262-7266
• Moll, U.M., Laquaglia, M., Benard, J., Riou, G., Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors (1995) Proc Natl Acad Sci U S A, 92 (10), pp. 4407-4411
• Monte, M., Simonatto, M., Peche, L.Y., Bublik, D.R., Gobessi, S., Pierotti, M.A., Rodolfo, M., Schneider, C., MAGE-A tumor antigens target p53 transactivation function through histone deacety-lase recruitment and confer resistance to chemotherapeutic agents (2006) Proc Natl Acad Sci U S A, 103 (30), pp. 11160-11165
• Morey, L., Helin, K., Polycomb group protein-mediated repression of transcription (2010) Trends Biochem Sci, 35 (6), pp. 323-332
• Moroni, M.C., Hickman, E.S., Lazzerini Denchi, E., Caprara, G., Colli, E., Cecconi, F., Muller, H., Helin, K., Apaf-1 is a transcriptional target for E2F and p53 (2001) Nat Cell Biol, 3 (6), pp. 552-558
• Muller, P.A., Vousden, K.H., P53 mutations in cancer (2013) Nat Cell Biol, 15 (1), pp. 2-8
• Muller, P.A., Vousden, K.H., Mutant p53 in cancer: New functions and therapeutic opportunities (2014) Cancer Cell, 25 (3), pp. 304-317
• Muller, M., Wilder, S., Bannasch, D., Israeli, D., Lehlbach, K., Li-Weber, M., Friedman, S.L., Krammer, P.H., P53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs (1998) J Exp Med, 188 (11), pp. 2033-2045
• Murray-Zmijewski, F., Lane, D.P., Bourdon, J.C., P53/p63/p73 isoforms: An orchestra of isoforms to harmonise cell differentiation and response to stress (2006) Cell Death Differ, 13 (6), pp. 962-972
• Nakano, K., Vousden, K.H., PUMA, a novel proapoptotic gene, is induced by p53 (2001) Mol Cell, 7 (3), pp. 683-694
• Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Tanaka, N., Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis (2000) Science, 288 (5468), pp. 1053-1058
• Oliner, J.D., Pietenpol, J.A., Thiagalingam, S., Gyuris, J., Kinzler, K.W., Vogelstein, B., Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 (1993) Nature, 362 (6423), pp. 857-860
• Pearson, M., Carbone, R., Sebastiani, C., Cioce, M., Fagioli, M., Saito, S., Higashimoto, Y., Pelicci, P.G., PML regulates p53 acetylation and premature senescence induced by oncogenic Ras (2000) Nature, 406 (6792), pp. 207-210
• Petitjean, A., Achatz, M.I., Borresen-Dale, A.L., Hainaut, P., Olivier, M., TP53 mutations in human cancers: Functional selection and impact on cancer prognosis and outcomes (2007) Oncogene, 26 (15), pp. 2157-2165
• Purdie, C.A., Harrison, D.J., Peter, A., Dobbie, L., White, S., Howie, S.E., Salter, D.M., Hooper, M.L., Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene (1994) Oncogene, 9 (2), pp. 603-609
• Rao, B., Lain, S., Thompson, A.M., P53-based cyclotherapy: Exploiting the ‘guardian of the genome’ to protect normal cells from cytotoxic therapy (2013) Br J Cancer, 109 (12), pp. 2954-2958
• Reles, A., Wen, W.H., Schmider, A., Gee, C., Runnebaum, I.B., Kilian, U., Jones, L.A., Press, M.F., Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer (2001) Clin Cancer Res, 7 (10), pp. 2984-2997
• Riley, M.F., Lozano, G., The many faces of MDM2 binding partners (2012) Genes Cancer, 3 (3-4), pp. 226-239
• Riley, T., Sontag, E., Chen, P., Levine, A., Transcriptional control of human p53-regulated genes (2008) Nat Rev Mol Cell Biol, 9 (5), pp. 402-412
• Rodriguez, R., Rubio, R., Menendez, P., Modeling sarcomagenesis using multipotent mesenchymal stem cells (2012) Cell Res, 22 (1), pp. 62-77
• Rogel, A., Popliker, M., Webb, C.G., Oren, M., P53 cellular tumor antigen: Analysis of mRNA levels in normal adult tissues, embryos, and tumors (1985) Mol Cell Biol, 5 (10), pp. 2851-2855
• Rubio, R., Garcia-Castro, J., Gutierrez-Aranda, I., Paramio, J., Santos, M., Catalina, P., Leone, P.E., Rodriguez, R., Deficiency in p53 but not retinoblastoma induces the transformation of mesenchymal stem cells in vitro and initiates leiomyosarcoma in vivo (2010) Cancer Res, 70 (10), pp. 4185-4194
• Sabapathy, K., Klemm, M., Jaenisch, R., Wagner, E.F., Regulation of ES cell differentiation by functional and conformational modulation of p53 (1997) Embo J, 16 (20), pp. 6217-6229
• Sax, J.K., Fei, P., Murphy, M.E., Bernhard, E., Korsmeyer, S.J., El-Deiry, W.S., BID regulation by p53 contributes to chemosensitivity (2002) Nat Cell Biol, 4 (11), pp. 842-849
• Scheffner, M., Werness, B.A., Huibregtse, J.M., Levine, A.J., Howley, P.M., The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 (1990) Cell, 63 (6), pp. 1129-1136
• Scherz-Shouval, R., Weidberg, H., Gonen, C., Wilder, S., Elazar, Z., Oren, M., P53-dependent regulation of autophagy protein LC3 supports cancer cell survival under prolonged starvation (2010) Proc Natl Acad Sci U S A, 107 (43), pp. 18511-18516
• Schwartzenberg-Bar-Yoseph, F., Armoni, M., Karnieli, E., The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression (2004) Cancer Res, 64 (7), pp. 2627-2633
• Selivanova, G., Therapeutic targeting of p53 by small molecules (2010) Semin Cancer Biol, 20 (1), pp. 46-56
• Shangary, S., Wang, S., Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: A novel approach for cancer therapy (2009) Annu Rev Pharmacol Toxicol, 49, pp. 223-241
• Shelling, A.N., Role of p53 in drug resistance in ovarian cancer (1997) Lancet, 349 (9054), pp. 744-745
• Stambolsky, P., Weisz, L., Shats, I., Klein, Y., Goldfinger, N., Oren, M., Rotter, V., Regulation of AIF expression by p53 (2006) Cell Death Differ, 13 (12), pp. 2140-2149
• Stegh, A.H., Targeting the p53 signaling pathway in cancer therapy - the promises, challenges and perils (2012) Expert Opin Ther Targets, 16 (1), pp. 67-83
• Stott, F.J., Bates, S., James, M.C., Mc Connell, B.B., Starborg, M., Brookes, S., Palmero, I., Peters, G., The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2 (1998) Embo J, 17 (17), pp. 5001-5014
• Takahashi, K., Yamanaka, S., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors (2006) Cell, 126 (4), pp. 663-676
• Tan, M., Li, S., Swaroop, M., Guan, K., Oberley, L.W., Sun, Y., Transcriptional activation of the human glutathione peroxidase promoter by p53 (1999) J Biol Chem, 274 (17), pp. 12061-12066
• Van Leeuwen, I.M., Rao, B., Sachweh, M.C., Lain, S., An evaluation of small-molecule p53 activators as chemoprotectants ameliorating adverse effects of anticancer drugs in normal cells (2012) Cell Cycle, 11 (9), pp. 1851-1861
• Ventura, A., Kirsch, D.G., Mc Laughlin, M.E., Tuveson, D.A., Grimm, J., Lintault, L., Newman, J., Jacks, T., Restoration of p53 function leads to tumour regression in vivo (2007) Nature, 445 (7128), pp. 661-665
• Vogelstein, B., Lane, D., Levine, A.J., Surfing the p53 network (2000) Nature, 408 (6810), pp. 307-310
• Vousden, K.H., Lane, D.P., P53 in health and disease (2007) Nat Rev Mol Cell Biol, 8 (4), pp. 275-283
• Vousden, K.H., Ryan, K.M., P53 and metabolism (2009) Nat Rev Cancer, 9 (10), pp. 691-700
• Wade, M., Li, Y.C., Wahl, G.M., MDM2, MDMX and p53 in oncogenesis and cancer therapy (2013) Nat Rev Cancer, 13 (2), pp. 83-96
• Wei, J., Zaika, E., Zaika, A., P53 family: Role of protein isoforms in human cancer (2012) J Nucleic Acids, 2012, pp. 687359
• Wise, D.R., Deberardinis, R.J., Mancuso, A., Sayed, N., Zhang, X.Y., Pfeiffer, H.K., Nissim, I., Thompson, C.B., Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction (2008) Proc Natl Acad Sci U S A, 105 (48), pp. 18782-18787
• Wu, G.S., Burns, T.F., Mc Donald, E.R., III, Jiang, W., Meng, R., Krantz, I.D., Kao, G., El-Deiry, W.S., KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene (1997) Nat Genet, 17 (2), pp. 141-143
• Xirodimas, D.P., Saville, M.K., Bourdon, J.C., Hay, R.T., Lane, D.P., Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity (2004) Cell, 118 (1), pp. 83-97
• Xue, W., Zender, L., Miething, C., Dickins, R.A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., Lowe, S.W., Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas (2007) Nature, 445 (7128), pp. 656-660
• Yang, A., Walker, N., Bronson, R., Kaghad, M., Oosterwegel, M., Bonnin, J., Vagner, C., Caput, D., P73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours (2000) Nature, 404 (6773), pp. 99-103
• Yang, A., Kaghad, M., Caput, D., Mc Keon, F., On the shoulders of giants: P63, p73 and the rise of p53 (2002) Trends Genet, 18 (2), pp. 90-95
• Yang, B., O'herrin, S.M., Wu, J., Reagan-Shaw, S., Ma, Y., Bhat, K.M., Gravekamp, C., Longley, B.J., MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines (2007) Cancer Res, 67 (20), pp. 9954-9962
• Yeung, S.J., Pan, J., Lee, M.H., Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer (2008) Cell Mol Life Sci, 65 (24), pp. 3981-3999

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------